THOR is a targetable epigenetic biomarker with clinical implications in breast cancer

Breast cancer (BC) is the most frequently diagnosed cancer and a leading cause of death among women worldwide. Early BC is potentially curable, but the mortality rates still observed among BC patients demonstr...

Source: Clinical Epigenetics - December 18, 2022 Category: Research Authors: Joana Dias Apol ónio, João S. Dias, Mónica Teotónio Fernandes, Martin Komosa, Tatiana Lipman, Cindy H. Zhang, Ricardo Leão, Donghyun Lee, Nuno Miguel Nunes, Ana-Teresa Maia, José L. Morera, Luis Vicioso, Uri Tabori and Pedro Castelo-Branco Tags: Research Source Type: research